Terms: = Cervical cancer AND CCND3, P30281, 896, ENSG00000112576 AND Prognosis
4 results:
1. Identification and validation of serum tumor-markers based nomogram to predict the prognostic value of patients with cervical adenocarcinoma.
Liu Y; Shi L; Chen K; Ye W
Curr Probl Cancer; 2022 Dec; 46(6):100899. PubMed ID: 36270166
[TBL] [Abstract] [Full Text] [Related]
2. A Novel Prognostic Risk Model for cervical cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
Xu HH; Wang HL; Xing TJ; Wang XQ
Front Immunol; 2022; 13():851622. PubMed ID: 35924232
[TBL] [Abstract] [Full Text] [Related]
3. A new score based on biomarker values to predict the prognosis of locally advanced cervical cancer.
Maulard A; Chargari C; Faron M; Alwohaibi A; Leary A; Pautier P; Genestie C; Morice P; Gouy S
Gynecol Oncol; 2020 Nov; 159(2):534-538. PubMed ID: 32828580
[TBL] [Abstract] [Full Text] [Related]
4. Multiparametric MRI-Based Radiomics Nomogram for Predicting Lymph Node Metastasis in Early-Stage cervical cancer.
Xiao M; Ma F; Li Y; Li Y; Li M; Zhang G; Qiang J
J Magn Reson Imaging; 2020 Sep; 52(3):885-896. PubMed ID: 32096586
[TBL] [Abstract] [Full Text] [Related]
